Arama Sonuçları
Tüm Sonuçları Gör
Createx Createx Createx
Home
Reels
Gruplar
Sayfalar
Market
Daha fazla gör
Gruplar Sayfalar Market Events Blogs Funding Offers Jobs Courses Forums Movies Oyunlar Merits
Katıl
Giriş yapın Başvur
Theme Switcher
Night Mode
Site içinde arama yapın
Yazı
Blogs
Kullanıcılar
Sayfalar
Gruplar
Events
  • Travis Rohrer @globalbusinesstrends bir ses eklendi in Others
    2025-10-27 09:07:00 · Translate ·
    DNA and mRNA Veterinary Vaccines Market Challenges: Growth, Share, Value, Size, and Scope By 2032
    Executive Summary DNA and mRNA Veterinary Vaccines Market Market Size and Share Analysis Report The global DNA and mRNA veterinary vaccines market size was valued at USD 343.15 million in 2024 and is projected to reach USD 862.45 million by 2032, with a CAGR of 12.21% during the forecast period of 2025 to 2032. Businesses are very much depending on the diverse segments involved in the...
    0 Yorumlar ·0 hisse senetleri ·613 Views ·0 önizleme
    Please log in to like, share and comment!
  • Travis Rohrer @globalbusinesstrends bir ses eklendi in Others
    2025-09-09 08:56:47 · Translate ·
    DNA and mRNA Veterinary Vaccines Market Companies: Growth, Share, Value, Size, and Insights By 2033
    Executive Summary DNA and mRNA Veterinary Vaccines Market: Share, Size & Strategic Insights CAGR Value: The global DNA and mRNA veterinary vaccines market size was valued at USD 343.15 million in 2024 and is projected to reach USD 862.45 million by 2032, with a CAGR of 12.21% during the forecast period of 2025 to 2032.  The comprehensive DNA and mRNA Veterinary Vaccines...
    0 Yorumlar ·0 hisse senetleri ·1K Views ·0 önizleme
    Please log in to like, share and comment!
  • Komal Galande @komal007 bir ses eklendi in Fashion and Art
    2025-12-12 07:51:27 · Translate ·
    RNA Therapeutics Market Soars with Breakthroughs in Gene-Based Treatment Technologies
    Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA Therapeutics...
    0 Yorumlar ·0 hisse senetleri ·23 Views ·0 önizleme
    Please log in to like, share and comment!
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsorluk
© 2025 Createx
Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Contact Us Rehber